Does BELATACEPT Cause Infusion site extravasation? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Infusion site extravasation have been filed in association with BELATACEPT (NULOJIX). This represents 0.3% of all adverse event reports for BELATACEPT.
11
Reports of Infusion site extravasation with BELATACEPT
0.3%
of all BELATACEPT reports
0
Deaths
0
Hospitalizations
How Dangerous Is Infusion site extravasation From BELATACEPT?
Of the 11 reports.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELATACEPT. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does BELATACEPT Cause?
Off label use (304)
Death (206)
Transplant rejection (178)
Cytomegalovirus infection (142)
Drug ineffective (142)
Product storage error (142)
Acute kidney injury (137)
Covid-19 (129)
Hospitalisation (123)
Kidney transplant rejection (97)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which BELATACEPT Alternatives Have Lower Infusion site extravasation Risk?
BELATACEPT vs BELIMUMAB
BELATACEPT vs BELINOSTAT
BELATACEPT vs BELUMOSUDIL
BELATACEPT vs BELVIQ
BELATACEPT vs BELZUTIFAN